Vol 2, No 4 (2010)
Mol Cell Pharmacol
Table of Contents
PharmSights
| mTOR Signaling and Entrainment of the Mammalian Circadian Clock | Abstract PDF |
| Ruifeng Cao, Karl Obrietan | 125-130 |
| Intracellular Distribution-based Anticancer Drug Targeting: Exploiting a Lysosomal Acidification Defect Associated with Cancer Cells | Abstract PDF |
| Rosemary A. Ndolo, Damon T. Jacobs, M. Laird Forrest, Jeffrey P. Krise | 131-136 |
| Vascular Endothelial Growth Factor Regulates Excitatory Synaptic Transmission in Hippocampal Neurons | Abstract PDF |
| Yu-Fei Huang, Chih-Hao Yang, Chiuan-Shiou Chiou, Chiung-Chun Huang, Kuei-Sen Hsu | 137-141 |
Research Articles
| Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase | Abstract PDF |
| Stacey L. House, Brian E. House, Betty Glascock, Thomas Kimball, Eyad Nusayr, Jo El J. Schultz, Thomas Doetschman | 143-154 |
| Glyceollins, a Novel Class of Antiestrogenic Phytoalexins | Abstract PDF |
| Syreeta L. Tilghman, Stephen M. Boué, Matthew E. Burow | 155-160 |
| Soluble Neuregulin and Schwann Cell Myelination: a Therapeutic Potential for Improving Remyelination of Adult Axons | Abstract PDF |
| Neeraja Syed, Haesun A. Kim | 161-167 |
FDA Corner
| FDA Approves First Oral Drug to Reduce MS Relapses | Abstract PDF |
| 169 |
| FDA Approves New Drug for Gout | Abstract PDF |
| 169-170 |
| FDA Approves Drug for Chronic Drooling in Children | Abstract PDF |
| 170 |
| FDA Approves New Treatment for Prostate Cancer | Abstract PDF |
| 170-171 |
Our partner: Crossroads Pharmacy 2800 Hwy 101, Rogersville, AL 35652 LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 Copyright © 2008 LumiText Publishing. All rights reserved.